| |
Company
Roster
|
|
Total
Insiders : |
58 |
|
|
|
Total
Direct Shares :
|
41,803,223 |
|
|
Total
Indirect Shares :
|
4,355,125 |
| |
%
Held by Insiders:
|
20.11% |
|
|
| |
| Filer's Name |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
  Gunther Scott |
SVP, Quality & Reg. Affairs |
2024-03-15 |
29,506 |
|
0 |
| Kreuzburg Christa |
Director |
2024-01-25 |
18,283 |
2018-08-23 |
0 |
| Hatzfeld Michael |
Chief Accounting Officer |
2024-01-16 |
7,908 |
2024-01-16 |
0 |
| Maselli Alessandro |
President & CEO, Director |
2023-12-08 |
87,938 |
2016-09-08 |
0 |
| Gennadios Aristippos |
Group Pres. Pharma & Consumer |
2023-12-08 |
96,496 |
|
0 |
| Hopson Ricky |
Pres. Clinical Dev Supply Div |
2023-12-08 |
22,018 |
2021-06-01 |
0 |
| Okey Stephanie |
Director |
2023-10-27 |
7,972 |
2023-08-28 |
0 |
| Stahl Jack L |
Director |
2023-10-27 |
43,321 |
|
0 |
| Flynn Karen |
Director |
2023-10-27 |
24,339 |
2020-01-08 |
0 |
| Carroll J Martin |
Director |
2023-10-27 |
28,071 |
2022-10-27 |
11,663 |
| Damelio Frank A |
Director |
2023-10-27 |
7,972 |
2023-08-28 |
0 |
| Crane Rosemary A |
Director |
2023-10-27 |
23,873 |
2018-08-23 |
0 |
| Classon Rolf A |
Director |
2023-10-27 |
43,321 |
|
0 |
| Lucier Gregory T |
Director |
2023-10-27 |
32,251 |
2021-11-23 |
0 |
| Balachandran Madhavan |
Director |
2023-10-27 |
27,441 |
|
0 |
| Barber Michael J |
Director |
2023-10-27 |
13,389 |
2021-04-28 |
0 |
| Morel Donald E Jr |
Director |
2023-10-27 |
65,455 |
|
0 |
| Ryan Michelle R |
Director |
2023-10-27 |
8,972 |
2023-08-28 |
0 |
| Barg Steven |
Director |
2023-10-27 |
7,711 |
2023-09-10 |
0 |
| Mcerlane David |
Officer |
2023-10-25 |
19,552 |
|
0 |
| Ferraro Joseph Anthony |
SVP, General Counsel, CCO |
2023-10-17 |
7,853 |
2023-08-01 |
0 |
| Hunt Patricia |
Pres. Consumer Health Div |
2023-10-16 |
11,267 |
2022-08-24 |
0 |
| Arnold Jonathan |
SVP, CCO & Div. Head BioP Del. |
2023-08-24 |
55,896 |
2018-07-23 |
0 |
| Fasman Steven L |
EVP & Chief Admin Officer |
2023-08-24 |
72,380 |
2014-10-23 |
0 |
| Lickfold Charles |
SVP, CIO |
2023-08-24 |
10,892 |
|
0 |
| Grippo Michael J |
SVP, Strategy & Corp. Dev. |
2023-08-24 |
23,725 |
|
0 |
| Hawkeswood Thomas W |
Pres. Pharma Prod Delivery Div |
2023-08-24 |
7,412 |
2022-08-24 |
0 |
| Pravda Ricardo |
Chief Transformation Officer |
2023-08-24 |
29,522 |
|
0 |
| Carletti Lorenzo |
SVP Global Ops Ph & Cons Hlth |
2023-08-24 |
8,505 |
|
0 |
| Zayas Ricardo |
SVP, Operations, Biologics NA |
2023-08-01 |
6,223 |
|
0 |
| Santiago Karen Murphy |
VP & Chief Accounting Officer |
2023-08-01 |
4,763 |
2022-09-19 |
0 |
| Masanovich Matti |
SVP, Chief Financial Officer |
2023-07-05 |
36,864 |
2023-07-05 |
0 |
| Gargiulo Mario |
SVP, Ops, Biologics Europe |
2023-05-01 |
5,676 |
|
0 |
| Boerman Manja |
Pres. BioModalities Division |
2023-05-01 |
14,414 |
2022-08-24 |
0 |
| Zippelius Peter |
Director |
2022-10-27 |
11,979 |
2022-10-27 |
4,330,462 |
| Greisch John J |
Director |
2022-10-27 |
16,880 |
2022-10-27 |
13,000 |
| Riley Michael A. |
Pres. Bio Product Delivery Div |
2022-08-26 |
6,592 |
2022-08-24 |
0 |
| Castellano Thomas P |
SVP, Chief Financial Officer |
2022-08-25 |
20,099 |
2021-06-01 |
0 |
| Chiminski John R |
Executive Chair, Director |
2022-08-25 |
229,888 |
|
0 |
| Schmidt Kay A |
SVP, Enterprise Functions |
2022-08-25 |
17,388 |
|
0 |
| Whitlow Ricci S |
President, CSS |
2022-01-21 |
2,923 |
2020-01-20 |
0 |
| Joseph Wetteny |
SVP & Chief Financial Officer |
2021-02-16 |
49,823 |
2015-10-13 |
0 |
| Buzy Peter L |
President, Gene Therapy |
2020-04-09 |
45,950 |
2019-05-29 |
0 |
| Littlejohns Barry |
President, Biologics & SDD |
2019-08-22 |
45,882 |
|
0 |
| Hegwood Paul W Jr |
President, CSS |
2019-08-22 |
11,848 |
2018-08-23 |
0 |
| Miyamoto Lance |
SVP, Human Resources |
2019-03-07 |
46,799 |
|
0 |
| Downie William |
SVP, Global Sales & Marketing |
2019-02-15 |
34,926 |
|
0 |
| Roehrhoff Uwe |
Director |
2017-11-21 |
16,489 |
|
0 |
| Dolan Christine |
SVP - Product Development |
2017-08-29 |
19,449 |
2016-09-13 |
0 |
| Quella James |
Director |
2017-08-24 |
20,641 |
|
0 |
| Walsh Matthew M |
EVP & Chief Financial Officer |
2017-08-24 |
103,703 |
|
0 |
| Johnson Sharon |
See Remarks |
2017-04-25 |
30,829 |
|
0 |
| Booth Melvin D |
Director |
2016-08-24 |
16,665 |
|
0 |
| Leonard Stephen |
See Remarks |
2016-07-26 |
51,741 |
|
0 |
| Houlton Scott |
See Remarks |
2015-08-27 |
36,912 |
|
0 |
| Blackstone Healthcare Partners L.l.c. |
10% Owner |
2015-04-14 |
40,030,960 |
2015-04-14 |
0 |
| Kurt Nielsen |
See Remarks |
2015-02-17 |
23,676 |
|
0 |
| Schwarzman Stephen A |
10% Owner |
|
0 |
2016-09-09 |
0 |
|
|
0.15 (0.27%) 
